Upwards arrow: Go back to top

Join us on LinkedIn for the latest news.

Friday, September 18, 2026

Scripta Therapeutics: AI-Powered Drug Discovery for Neurodegenerative Diseases

Scripta Therapeutics

Scripta Therapeutics is a techbio company using AI and multi-omics to identify and develop novel therapeutics by targeting transcription factors that drive disease, initially focusing on neurodegenerative diseases such as Alzheimer’s,Parkinson’s and ALS. (scriptatherapeutics.com)

Deal Origin:

Company built with Oxford University and Oxford Science Enterprises

Location:

Oxford,United Kingdom

Build with: